Notify me when Regal Partners Ltd files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 97 | $1,734,313,092 | +$381,992,436 | -$194,326,727 | +$187,665,709 | NEM, TECK, FCX, APO, BAC | 13F-HR | 17 Feb 2026, 20:49 |
| Q3 2025 | 86 | $1,397,801,512 | +$228,134,305 | -$186,395,236 | +$41,739,069 | NEM, TECK, BAC, WYNN, FCX | 13F-HR | 12 Nov 2025, 21:55 |
| Q2 2025 | 76 | $1,183,328,939 | +$196,026,615 | -$108,807,557 | +$87,219,058 | FCX, TECK, NEM, WYNN, BAC | 13F-HR | 04 Aug 2025, 21:25 |
| Q1 2025 | 49 | $976,414,231 | +$139,531,103 | -$143,483,619 | -$3,952,516 | NEM, TECK, WYNN, BAC, FCX | 13F-HR | 12 May 2025, 19:52 |
| Q4 2024 | 56 | $987,672,262 | +$140,606,025 | -$256,782,002 | -$116,175,977 | TECK, BAC, APO, WYNN, FCX | 13F-HR | 14 Feb 2025, 17:12 |
| Q3 2024 | 48 | $1,131,464,315 | +$192,753,984 | -$91,753,977 | +$101,000,007 | TECK, FCX, APO, WYNN, BAC | 13F-HR | 05 Nov 2024, 19:51 |
| Q2 2024 | 46 | $965,461,662 | +$200,829,020 | -$238,094,756 | -$37,265,736 | TECK, APO, BAC, WYNN, WFC | 13F-HR | 01 Aug 2024, 20:11 |
| Q1 2024 | 49 | $994,883,047 | +$166,390,250 | -$213,278,870 | -$46,888,620 | TECK, APO, FCX, BAC, WYNN | Restatement | 14 May 2024, 19:27 |
| Q4 2023 | 40 | $940,245,322 | +$609,670,944 | -$151,987,883 | +$457,683,061 | TECK, FCX, APO, BAC, WYNN | Restatement | 14 May 2024, 19:29 |
| Q3 2023 | 40 | $448,027,678 | +$159,228,933 | -$159,175,151 | +$53,782 | KVUE, TECK, CME, GEHC, AMZN | 13F-HR | 13 Nov 2023, 18:52 |
| Q2 2023 | 33 | $461,373,368 | +$120,382,349 | -$199,219,783 | -$78,837,434 | CME, AMZN, GEHC, SLB, PINS | 13F-HR | 14 Aug 2023, 19:34 |
| Q1 2023 | 35 | $512,866,517 | +$139,177,561 | -$112,475,212 | +$26,702,349 | AMZN, CME, DIS, GEHC, PINS | 13F-HR | 15 May 2023, 17:29 |
| Q4 2022 | 37 | $427,931,794 | +$73,269,701 | -$95,272,958 | -$22,003,257 | AMZN, CME, PINS, MA, DIS | Restatement | 15 Aug 2023, 19:24 |
| Q3 2022 | 34 | $476,581,000 | +$46,864,356 | -$135,707,401 | -$88,843,045 | AMZN, CME, MA, PINS, SLB | Restatement | 15 Aug 2023, 19:20 |
| Q2 2022 | 32 | $587,602,000 | +$184,806,813 | -$42,308,094 | +$142,498,719 | AMZN, CME, MA, PINS, TWTR | Restatement | 09 Sep 2022, 12:38 |
| Q1 2022 | 17 | $772,420,000 | +$86,169,648 | -$60,328,932 | +$25,840,716 | AMZN, CME, MA, XM, PINS | 13F-HR | 16 May 2022, 10:01 |
| Q4 2021 | 14 | $833,665,000 | +$34,949,232 | -$59,497,744 | -$24,548,512 | AMZN, MA, CME, PINS, XM | 13F-HR | 14 Feb 2022, 16:21 |
| Q3 2021 | 14 | $910,267,000 | +$11,756,704 | -$230,807,469 | -$219,050,765 | AMZN, MA, PINS, CME, XM | 13F-HR | 15 Nov 2021, 15:01 |
| Q2 2021 | 18 | $1,263,685,000 | +$252,281,977 | -$199,137,155 | +$53,144,822 | AMZN, PINS, MA, CME, OTIS | 13F-HR | 16 Aug 2021, 10:51 |
| Q1 2021 | 16 | $1,129,307,000 | +$177,678,734 | -$45,374,325 | +$132,304,409 | AMZN, MA, PINS, CME, OTIS | 13F-HR | 14 May 2021, 19:19 |
| Q4 2020 | 13 | $968,949,000 | +$151,317,106 | -$46,615,790 | +$104,701,316 | AMZN, MA, PINS, CME, OTIS | 13F-HR | 16 Feb 2021, 10:41 |
| Q3 2020 | 7 | $756,505,000 | +$128,551,960 | -$297,515,417 | -$168,963,457 | AMZN, MA, CME, PINS, OTIS | 13F-HR | 16 Nov 2020, 13:47 |
| Q2 2020 | 9 | $851,242,000 | +$59,064,000 | -$261,986,886 | -$202,922,886 | AMZN, MA, LIN, CME, CL | 13F-HR | 14 Aug 2020, 10:16 |
| Q1 2020 | 8 | $928,179,000 | +$22,595,495 | -$235,649,029 | -$213,053,534 | CME, AMZN, MA, LIN, SPOT | 13F-HR | 15 May 2020, 15:57 |
| Q4 2019 | 10 | $1,267,009,000 | +$33,022,797 | -$781,276 | +$32,241,521 | CME, AMZN, MA, CL, SPOT | 13F-HR | 14 Feb 2020, 14:44 |
| Q3 2019 | 10 | $1,168,335,000 | +$40,443,717 | -$30,831,166 | +$9,612,551 | CME, AMZN, MA, CL, LIN | 13F-HR | 14 Nov 2019, 14:39 |
| Q2 2019 | 10 | $1,183,605,000 | +$134,232,570 | -$18,189,000 | +$116,043,570 | CME, AMZN, MA, CL, SPOT | 13F-HR | 14 Aug 2019, 16:34 |
| Q1 2019 | 11 | $985,654,000 | +$14,205,190 | -$42,588,977 | -$28,383,787 | CME, AMZN, MA, CL, LIN | 13F-HR | 14 May 2019, 09:18 |
| Q4 2018 | 10 | $927,555,000 | +$197,157,679 | -$126,045,000 | +$71,112,679 | CME, AMZN, CL, MA, LIN | 13F-HR | 14 Feb 2019, 09:57 |
| Q3 2018 | 11 | $962,186,000 | +$59,819,192 | -$45,960,066 | +$13,859,126 | CME, AMZN, MA, CL, PX | 13F-HR | 14 Nov 2018, 14:47 |
| Q2 2018 | 11 | $909,162,000 | +$75,122,964 | -$33,899,223 | +$41,223,741 | CME, AMZN, MA, CL, PX | 13F-HR | 14 Aug 2018, 10:35 |
| Q1 2018 | 11 | $818,407,000 | +$125,409,139 | -$62,156,459 | +$63,252,680 | CME, AMZN, MA, CL, KO | 13F-HR | 11 May 2018, 17:02 |
| Q4 2017 | 10 | $690,487,000 | +$179,722,832 | -$29,856,253 | +$149,866,579 | CME, AMZN, MA, Z, CL | 13F-HR | 14 Feb 2018, 09:15 |
| Q3 2017 | 11 | $494,064,000 | +$45,920,833 | -$27,212,000 | +$18,708,833 | CME, MA, AMZN, Z, PX | 13F-HR | 14 Nov 2017, 09:44 |
| Q2 2017 | 10 | $457,900,000 | +$40,838,479 | -$122,228,732 | -$81,390,253 | CME, AMZN, MA, Z, PX | 13F-HR | 14 Aug 2017, 10:15 |
| Q1 2017 | 12 | $505,929,000 | +$90,635,007 | $0 | +$90,635,007 | CME, MA, AMZN, MJN, NLSN | 13F-HR | 15 May 2017, 09:01 |
| Q4 2016 | 10 | $396,741,000 | +$69,894,424 | -$50,284,969 | +$19,609,455 | CME, MA, AMZN, Z, NLSN | 13F-HR | 14 Feb 2017, 14:38 |
| Q3 2016 | 10 | $383,978,000 | +$35,806,791 | -$7,537,944 | +$28,268,847 | CME, MA, AMZN, MJN, Z | 13F-HR | 14 Nov 2016, 16:41 |
| Q2 2016 | 11 | $345,048,000 | +$10,874,091 | -$41,821,414 | -$30,947,323 | CME, MA, MJN, AMZN, Z | 13F-HR | 15 Aug 2016, 12:17 |
| Q1 2016 | 11 | $353,246,000 | +$85,252,333 | -$30,532,084 | +$54,720,249 | CME, MA, MJN, AMZN, HOUS | 13F-HR | 13 May 2016, 16:25 |
| Q4 2015 | 12 | $293,735,000 | +$49,731,230 | -$17,295,271 | +$32,435,959 | MA, CME, AMZN, HOUS, WDFC | Restatement | 17 Feb 2016, 09:01 |
| Q3 2015 | 13 | $248,499,000 | +$50,984,189 | -$17,480,086 | +$33,504,103 | MA, CME, AMZN, HOUS, MRKT | 13F-HR | 13 Nov 2015, 15:09 |
| Q2 2015 | 12 | $228,999,000 | +$34,381,798 | -$27,511,048 | +$6,870,750 | MA, CME, HOUS, WDFC, AMZN | 13F-HR | 14 Aug 2015, 09:26 |
| Q1 2015 | 13 | $221,990,000 | +$53,253,451 | -$30,740,784 | +$22,512,667 | MA, CME, HOUS, WDFC, AMZN | 13F-HR | 15 May 2015, 09:23 |
| Q4 2014 | 10 | $189,539,000 | +$30,904,681 | -$57,451,338 | -$26,546,657 | CME, MA, HOUS, WDFC, Z | 13F-HR | 13 Feb 2015, 14:59 |
| Q3 2014 | 11 | $199,695,000 | +$69,393,233 | -$80,182,197 | -$10,788,964 | CME, HOUS, MNST, WDFC, Z | 13F-HR | 13 Nov 2014, 18:06 |
| Q2 2014 | 8 | $199,022,000 | +$220,000 | -$151,668,709 | -$151,448,709 | CME, MNST, MHFI, WDFC, FOX | Restatement | 05 Sep 2014, 17:15 |
| Q1 2014 | 11 | $341,938,000 | +$49,127,061 | -$22,734,991 | +$26,392,070 | HOUS, WWE, CME, MHFI, MNST | 13F-HR | 15 May 2014, 09:25 |
| Q4 2013 | 11 | $312,135,000 | $0 | $0 | $0 | HOUS, MHFI, CME, MNST, WWE | 13F-HR | 13 Feb 2014, 09:37 |